Literature DB >> 3778246

Cognitive function in recent-onset demyelinating diseases.

O Lyon-Caen, R Jouvent, S Hauser, M P Chaunu, N Benoit, D Widlöcher, F Lhermitte.   

Abstract

To determine cognitive disturbances in recent demyelinating disease, we studied 21 patients with definite or probable multiple sclerosis (MS) of less than two years' duration and nine patients with recently isolated optic neuritis. None had any clinical or social evidence of cognitive impairment. Mild to moderate cognitive impairment. Mild to moderate cognitive impairment was present in 18 (60%) of 30 cases, affecting visual and/or verbal efficiency. These abnormalities were statistically significant when compared with the results of a control group of 29 patients. There was no correlation with a depressive status, between the presence of cognitive impairment and either the degree of handicap or the activity of the disease. The frequency of cognitive dysfunction (60%) appears to be comparable to that reported in other series in which MS evolution is over ten years. The natural history of cognitive functions in MS has to be identified. Neuropsychologic tests could be useful in the diagnosis of monosymptomatic or paucisymptomatic forms of MS (ie, visual or medullary).

Entities:  

Mesh:

Year:  1986        PMID: 3778246     DOI: 10.1001/archneur.1986.00520110034010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  21 in total

1.  Multiple sclerosis and the mind.

Authors:  M A Ron; A Feinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

2.  Korsakoff's syndrome as the initial presentation of multiple sclerosis.

Authors:  A Vighetto; N Charles; M Salzmann; C Confavreux; G Aimard
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

3.  Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging.

Authors:  G P Anzola; L Bevilacqua; S F Cappa; R Capra; L Faglia; E Farina; G Frisoni; C Mariani; M P Pasolini; L A Vignolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

4.  Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both?

Authors:  H Brissart; E Morele; C Baumann; M Debouverie
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

5.  Effects of cannabis on cognitive function in patients with multiple sclerosis.

Authors:  Kimia Honarmand; Mary C Tierney; Paul O'Connor; Anthony Feinstein
Journal:  Neurology       Date:  2011-03-29       Impact factor: 9.910

Review 6.  The neuropsychology of multiple sclerosis: contributions of neuroimaging research.

Authors:  H A Wishart; L Flashman; A J Saykin
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

7.  Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.

Authors:  M S A Deloire; E Salort; M Bonnet; Y Arimone; M Boudineau; H Amieva; B Barroso; J-C Ouallet; C Pachai; E Galliaud; K G Petry; V Dousset; C Fabrigoule; B Brochet
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

8.  Cognitive impairment in probable multiple sclerosis.

Authors:  A Achiron; Y Barak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

9.  Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms.

Authors:  B Fontaine; D Seilhean; A Tourbah; C Daumas-Duport; C Duyckaerts; N Benoit; B Devaux; J J Hauw; G Rancurel; O Lyon-Caen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

10.  Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction.

Authors:  E Stenager; L Knudsen; K Jensen
Journal:  Ital J Neurol Sci       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.